<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

10.1001/jamaoncol.2022.6141

dc.identifier.other

WOS:000914628300003

dc.description.volume

dc.description.issue

Publisher

AMER MEDICAL ASSOC

DOI

10.1001/jamaoncol.2022.6141

Abstract

Description

Keywords

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By